Jump to content

Draft:Colossal Foundation

From Wikipedia, the free encyclopedia


Colossal Foundation is an American biotechnology organization, founded in October 2024 for US$50M, by Colossal Biosciences, a genetic engineering company known for his work on de-extinction technologies.[1]

The North Texas-based foundation aims to combat the extinction crisis with initiatives including Colossal Biovault, the world’s largest distributed biobanking initiative, and a host of new projects to preserve and de-extinct wildlife.[2][3]

Current projects

[edit]

The foundation aims to develop and use advanced technologies to address the global extinction crisis. This includes:

  • Species Conservation: Supporting initiatives to save endangered species like the vaquita, Smatran rhino, and Javan rhino.[2]
  • Ecosystem Restoration: Employing technological solutions to restore damaged ecosystems and enhance biodiversity.

Science and development

[edit]

The Colossal Foundation aims to achieve its goals through:

  • Technological Innovation: Developing and deploying novel technologies, including gene editing and bioengineering, to combat extinction.[4]
  • Partnerships: Collaborating with conservation organizations, research institutions, and local communities to implement effective conservation strategies.
  • Rapid Action: Prioritizing swift and impactful interventions to prevent further species loss.

Activities and history

[edit]
  • Researchers at the University of Melbourne in partnership with the Colossal Foundation will advance conservation efforts to engineer immunity in amphibians, including Australia’s critically endangered Corroboree frog, against a deadly fungal disease.[5]
  • Developing and deploying technological solutions: Investing in research and development of innovative technologies for conservation, such as gene editing for genetic rescue and advanced monitoring tools.
  • The Colossal Biovault collects tissue samples of endangered species in hopes to allow cell lines to become accessible and stored in domestic partner facilities. Its first projects include: Sumatran rhinoceros, vaquita, and ivory-billed woodpecker.[2]

References

[edit]
  1. ^ "The Colossal Foundation Aims to Save Threatened Species with De-Extinction Science". SYFY Official Site. 2024-10-01. Retrieved 2025-01-05.
  2. ^ a b c Innovates, Dallas; Murray, Lance (2024-10-01). "Colossal Launches The Colossal Foundation with $50M for 'BioVault' Biobanking, Genetic Rescues, and More". Dallas Innovates. Retrieved 2025-01-07.
  3. ^ "The Colossal Foundation Makes First Donation of US $1M as Part of $3M Commitment to Combat Chytrid Fungus, Save Amphibians from Mass Extinction, and Protect Endangered Ecosystems". Morningstar, Inc. 2024-12-16. Retrieved 2025-01-05.
  4. ^ Candid. "Colossal Biosciences launches foundation with $50 million". Philanthropy News Digest (PND). Retrieved 2025-01-07.
  5. ^ Fraser, Thomas (2024-12-17). "Engineering immunity in frogs to fight fungal disease". Newsroom. Retrieved 2025-01-05.